Kalshi traders see high odds that more than 5,100 data centers will be planned or operating before 2027

Impact · against what's priced in

The news is largely neutral for Oracle as the market already penalizes the company for its capital intensity and balance-sheet risks. Specific reports of project delays and regulatory hurdles in New Mexico reinforce the existing bear case regarding the company's ability to scale infrastructure without destroying shareholder value.

ORCL−0.10: Already priced in
The price assumes: The ability to fund massive AI infrastructure spending without permanently impairing shareholder value through dilution or high-cost debt

Kalshi traders see high odds that more than 5,100 data centers will be planned or operating before 2027

What matters in this story

Broadcom at $375: It Looks Like the Right Time to Add AVGO Shares

Kalshi traders see high odds that more than 5,100 data centers will be planned or operating before 2027

What matters in this story

Broadcom at $375: It Looks Like the Right Time to Add AVGO Shares

How each ticker is affected

Track these names every morning.

Micron Vs. Astera Labs: Who Has Evolved Into The More Complete Next Gen AI Threat?

Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers

How a Binance ‘High-Value Customer' Established a Financial Lifeline for Iran

Unlike The EV Narrative, Cybercab Does Not Need Tesla To Overcome An Entire Industry

Kalshi traders see high odds that more than 5,100 data centers will be planned or operating before 2027

What matters in this story

Next reads from the same story arc

Broadcom at $375: It Looks Like the Right Time to Add AVGO Shares

Kalshi traders see high odds that more than 5,100 data centers will be planned or operating before 2027

What matters in this story

Next reads from the same story arc

Broadcom at $375: It Looks Like the Right Time to Add AVGO Shares

How each ticker is affected

Track these names every morning.

Micron Vs. Astera Labs: Who Has Evolved Into The More Complete Next Gen AI Threat?

Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers

How a Binance ‘High-Value Customer' Established a Financial Lifeline for Iran

Unlike The EV Narrative, Cybercab Does Not Need Tesla To Overcome An Entire Industry